Early Life and Family
Mathias Boehringer is part of the Boehringer family, who established Boehringer Ingelheim in 1885 in Ingelheim am Rhein, Germany. The company initially produced ingredients for pharmacies, textile merchants, and the food industry. The family-owned company has grown to be one of the largest pharmaceutical companies globally.
Rise to Success
Mathias Boehringer's wealth stems from his ownership in Boehringer Ingelheim. The company has a strong focus on research and development, with investments of around €6.2 billion in 2024. Boehringer Ingelheim operates in the areas of human pharmaceuticals, animal health, and biopharmaceuticals. The company's key areas of interest include respiratory diseases, metabolism, immunology, oncology, and diseases of the central nervous system.
Key Business Strategies
Boehringer Ingelheim's success is driven by its focus on innovation and long-term strategies. The company has a global presence with key sites in Germany, the US, and China. In 2024, the company's net sales were €26.8 billion. Key products such as JARDIANCE® and OFEV® have driven growth in the Human Pharma division.
Philanthropy
Boehringer Ingelheim is involved in philanthropic initiatives through the Boehringer Ingelheim Cares Foundation. The foundation supports programs focused on healthcare access, STEM education, and strengthening the human-animal bond. The Boehringer Ingelheim Cares Foundation has donated over $37 million to support programs since 2001.
